PE firm Altaris scoops up AI drug development outfit Simulations Plus for $375M
This story is reported by Fierce Biotech. Read what other outlets are saying below, then open the original report for full details.
This story is reported by Fierce Biotech. Read what other outlets are saying below, then open the original report for full details.